Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector

Abstract

Limb-girdle muscular dystrophies 2C–F represent a family of autosomal recessive diseases caused by defects in sarcoglycan genes1. The cardiomyopathic hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary deficiency in δ-sarcoglycan2,3,4,5. We show here that acute sarcolemmal disruption occurs in this animal model during forceful muscle contraction. A recombinant adeno-associated virus vector encoding human δ-sarcoglycan conferred efficient and stable genetic reconstitution in the adult cardiomyopathic hamster when injected directly into muscle. A quantitative assay demonstrated that vector-transduced muscle fibers are stably protected from sarcolemmal disruption; there was no associated inflammation or immunologic response to the vector-encoded protein. Efficient gene transduction with rescue of the sarcoglycan complex in muscle fibers of the distal hindlimb was also obtained after infusion of recombinant adeno-associated virus into the femoral artery in conjunction with histamine-induced endothelial permeabilization. This study provides a strong rationale for the development of gene therapy for limb-girdle muscular dystrophy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Acute sarcolemmal disruption in clustered myocytes of BIO 14.6 hamster skeletal muscle after forceful contraction.
Figure 2: Sarcoglycan complex rescue.
Figure 3: Gene transfer across the endothelial barrier: Histamine and papaverine transiently increase permeability.
Figure 4: Rescue of the sarcoglycan complex in muscles throughout the adult BIO 14.

Similar content being viewed by others

References

  1. Bonnemann, C., McNally, E. & Kunkel, L. Beyond dystrophin: current progress in the muscular dystrophies. Curr. Opin. Pediatr. 8, 569 –582 (1996).

    Article  CAS  Google Scholar 

  2. Homburger, F., Baker, J., Nixon, C. & Whitney, R. Primary, generalized polymyopathy and necrosis in an inbred line of Syrian hamsters. Med. Exp. 6, 339–345 ( 1962).

    Google Scholar 

  3. Roberds, S. et al. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathyic hamster. J. Biol. Chem. 268, 11496– 11499 (1993).

    CAS  PubMed  Google Scholar 

  4. Nigro, V. et al. Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6, 601–607 (1997).

    Article  CAS  Google Scholar 

  5. Sakamoto, A. et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc. Natl. Acad. Sci. USA 94, 13873–13878 (1997).

    Article  CAS  Google Scholar 

  6. Worton, R. Muscular dystrophies: diseases of the dystrophin-glycoprotein complex. Science 270, 755–6 ( 1995).

    Article  CAS  Google Scholar 

  7. Fisher, K. et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med. 3, 306–312 (1997).

    Article  CAS  Google Scholar 

  8. Homburger, F., Baker, J., Wilgram, G., Caulfield, J. & Nixon, C. Hereditary dystrophy-like myopathy. The histopathology of hereditary dystrophy-like myopathy in Syrian hamsters. Arch. Pathol. 81, 302–7 ( 1966).

    CAS  PubMed  Google Scholar 

  9. Cox, G. et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364, 725–29 (1993).

    Article  CAS  Google Scholar 

  10. Ragot, T. et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647–650 (1993).

    Article  CAS  Google Scholar 

  11. Holt, K. et al. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglygan gene transfer. Mol. Cell 1, 841–848 (1998).

    Article  CAS  Google Scholar 

  12. Cox, G.A., Sunada, Y., Campbell, K.P. & Chamberlain, J.S. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nature Genet. 8, 333–339 (1994).

    Article  CAS  Google Scholar 

  13. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. & Sweeney, H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. 90, 3710–14 ( 1993).

    Article  CAS  Google Scholar 

  14. Straub, V., Rafael, J., Chamberlain, J. & Campbell, K. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375– 385 (1997).

    Article  CAS  Google Scholar 

  15. Deconinck, N., Ragot, T., Marechal, G., Perricaudet, M. & Gillis, J. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. USA 93, 3570–3574 (1996).

    Article  CAS  Google Scholar 

  16. DeMatteo, R., Chu, G., Chang, E., Barker, C. & Markmann, J. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J. Virol. 71, 5330–5 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Nielsen, H. Histamine-2 receptor antagonists as immunomodulators: new therapeutic views? Ann. Med. 28, 107–13 (1996).

    Article  CAS  Google Scholar 

  18. Stedman, H.H. et al. Nebulin cDNAs detect a 25-kilobase transcript in skeletal muscle and localize to human chromosome 2. Genomics 2, 1–7 (1988).

    Article  CAS  Google Scholar 

  19. Samulski, R., Chang, L. & Shenk, T. A recombinant plasmid–from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61, 3096-3101 (1987).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Sanes, J., Rubenstein, J. & Nicolas, J. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5, 3133–3142 (1986).

    Article  CAS  Google Scholar 

  21. Brumback, R.A. & and Leech, R.W. in Color Atlas of Muscle Histochemistry, 13;21 (PSG, Littleton, Massachusetts, 1984).

    Google Scholar 

Download references

Acknowledgements

Acknowledgments These studies were supported in part by grants from the National Institutes of Health (5PO1AR/NS43648) and the Muscular Dystrophy Association. L.S. is a research fellow of the American Heart Association. S.K. is a research fellow of the Association Francaise contre les Myopathies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hansell H. Stedman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greelish, J., Su, L., Lankford, E. et al. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat Med 5, 439–443 (1999). https://doi.org/10.1038/7439

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/7439

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing